New heart drug SGC001 takes first step in healthy volunteers
NCT ID NCT07079618
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single dose of the experimental drug SGC001 in 49 healthy adults to check its safety and how the body processes it. The drug is being developed for heart attacks, but this trial did not involve people with heart disease. The goal was to gather essential safety information before testing in patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anzhen Hospital Capital Medical University
Beijing, Beijing Municipality, 100013, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.